10.07.2025 07:00 | CREO | MicroBlate™ Flex begins lung tumour clinical study | Reach |
09.07.2025 09:41 | CREO | PDMR Options Revision | RNS |
30.06.2025 07:00 | CREO | Change of Nominated Adviser | RNS |
26.06.2025 11:08 | CREO | Result of AGM | RNS |
26.06.2025 07:00 | CREO | AGM Statement and Directorate Changes | RNS |
19.06.2025 14:09 | TRN, SPT, ROQ | UK shareholder meetings calendar - next 7 days | Alliance |
11.06.2025 07:00 | CREO | U.S. FDA clearance for SpydrBlade™ Flex | Reach |
02.06.2025 07:00 | CREO | Director/PDMR Shareholding | RNS |
30.05.2025 07:00 | CREO | Posting of AR&R and Notice of AGM | RNS |
28.05.2025 12:21 | CREO | Creo Medical hails US reimbursement milestone for Speedboat procedure | Alliance |
28.05.2025 07:00 | CREO | US Reimbursement milestone for Speedboat procedure | RNS |
27.05.2025 12:48 | MNG, CREO | Holding(s) in Company | RNS |
23.05.2025 16:25 | MNG, CREO | Holding(s) in Company | RNS |
22.05.2025 07:00 | CREO | Directorate changes | RNS |
19.05.2025 11:10 | CREO | Creo Medical has "positive outlook", despite widened 2024 loss | Alliance |
19.05.2025 07:00 | CREO | Final Results | RNS |
12.05.2025 14:24 | CER, KNOS, CREO | UK earnings, trading statements calendar - next 7 days | Alliance |
06.05.2025 07:00 | CREO | Notice of investor presentations | RNS |
15.04.2025 14:00 | CREO | Notice of Results | RNS |
01.04.2025 09:34 | CREO | Holding(s) in Company | RNS |
31.03.2025 12:17 | CREO | Holding(s) in Company | RNS |
26.03.2025 07:00 | CREO | Grant of Options | RNS |
20.03.2025 10:28 | CREO, POLB, OMG | TRADING UPDATES: Costain wins deal; Focusrite expects revenue hike | Alliance |
20.03.2025 07:00 | CREO | UK & EU Commercial launch of SpydrBlade™ Flex | Reach |
06.03.2025 07:00 | CREO | Appointment of Nominated Adviser and sole Broker | RNS |
17.02.2025 12:42 | CREO | Creo Medical full-year sales to fall short despite core progress | Alliance |
17.02.2025 07:00 | CREO | FY24 Trading Update | RNS |
12.02.2025 13:52 | CREO | Creo Medical completes sale of interest in European subsidiary | Alliance |
12.02.2025 11:00 | CREO | Completion of sale of 51% interest in subsidiary | RNS |
06.02.2025 09:00 | CREO | First Welsh adopter of Speedboat® technology | Reach |
03.02.2025 15:00 | CREO | Total Voting Rights | RNS |
21.01.2025 07:00 | CREO | Award of Shares under Share Incentive Plan | RNS |
15.01.2025 07:00 | CREO | First robotic-guided lung ablation cases commence | RNS |
18.12.2024 15:52 | AHT, UTG, BCG | DIRECTOR DEALINGS: Baltic Classifieds CEO Simkus banks GBP13 million | Alliance |
16.12.2024 07:00 | CREO | Director/PDMR Shareholding | RNS |
31.10.2024 16:36 | CREO | Total Voting Rights | RNS |
24.10.2024 15:27 | CREO | Director/PDMR Shareholding (Replacement) | RNS |
24.10.2024 14:33 | CREO | Director/PDMR Shareholding | RNS |
21.10.2024 10:06 | CREO | Director/PDMR Share Dealings | RNS |
18.10.2024 10:26 | CREO | Result of General Meeting & TVR | RNS |
17.10.2024 17:29 | CREO | Result of Retail Offer | RNS |
04.10.2024 07:00 | CREO | Extension of Retail Offer Closing Date | RNS |
01.10.2024 13:34 | FEN, MPO, CREO | EARNINGS: Savannah Energy swings to profit; Creo loss widens | Alliance |
01.10.2024 07:00 | CREO | Result of Placing | RNS |
30.09.2024 15:50 | CREO | Retail Offer for up to £5.0 million | RNS |
30.09.2024 15:46 | CREO | Half-year Report | RNS |
30.09.2024 15:45 | CREO | Proposed Placing, Launch of ABB, Retail Offer | RNS |
18.09.2024 12:00 | CREO | Strategic Partnership & 51% subsidiary cash sale | RNS |
29.08.2024 11:05 | CREO | Holding(s) in Company | RNS |
01.08.2024 07:00 | CREO | Award of Shares under Share Incentive Plan | RNS |